Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

1). It is now well established that antibodies that block the interaction between PD-1 on T cells and PD-L1 on tumor cells can boost T cell activity and proliferation, leading to enhanced ...

L-type calcium channel blockers reduce PD risk... These pharmacological properties of dihydropyridine-class calcium channel blockers were evident in the Ritz et al. study. By documenting the use ...